First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

BACKGROUND: The nadir value of the absolute neutrophil count (ANC) in the first cycle of chemotherapy is an effective predictor of subsequent neutropenic events. This study was designed to validate an earlier published study based on a retrospective data analysis from a prospective randomized clinic...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2003
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC314422/
https://ncbi.nlm.nih.gov/pubmed/12927041
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky